• Diagnosis​ ​Information​ ​and​ ​General​ ​Questions

  FDA Names AMP945, Potential IPF Treatment, an Orphan Drug

  Posted by Pulmonary Fibrosis News Moderator on June 8, 2020 at 10:06 am

  

  Orphan drug status gives incentives to companies to support development of treatments, like AMP945 by Amplia Therapeutics, for rare diseases. Click here to learn more.

  What are your thoughts on orphan drugs?

  Pulmonary Fibrosis News Moderator replied 4 years, 3 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply